| First posted | New trial filing | Phase | Status |
|---|---|---|---|
| 2026-09-21 | NCT07830433 Evaluation of the Efficacy of Zuberitamab Injection in Patients With Primary Membranous… | Phase 3 | Not Yet Recruiting |
| Phase 1 | 3 | |
| Phase 2 | 3 | |
| Phase 3 | 2 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT07830433 | Evaluation of the Efficacy of Zuberitamab Injection in Patients With Primary Membranous… | Primary Membranous Nephropathy | Not Yet Recruiting | 2026-09-21 |
| NCT04514419 | Treatment of Breast Cancer With Trastuzumab + HS627/ Pertuzumab + Docetaxel | Breast Cancer | Active, Not Recruiting | 2025-11-21 |
| Phase 2 | ||||
| NCT07498647 | Clinical Trial of BR2251 Tablets for Patients With Primary Gout and Hyperuricemia | Gout and Hyperuricemia | Not Yet Recruiting | 2026-03-27 |
| NCT07311538 | Phase IIa Study of BRY812 Monotherapy in Advanced Gynecological Malignancies | Advanced Gynecological Malignancies | Not Yet Recruiting | 2025-12-31 |
| NCT06642909 | A Phase II Study of Zuberitamab Injection in Patients With Primary Membranous Nephropathy | Primary Membranous Nephropathy | Active, Not Recruiting | 2025-11-20 |
| Phase 1 | ||||
| NCT06038058 | A Study of BRY812 for Injection Alone in Subjects With Advanced Malignancies | Advanced Malignancies | Recruiting | 2025-12-30 |
| NCT06937957 | A Study of BR111 in Patients With Advanced Malignancies | Advanced Malignancies | Recruiting | 2025-11-21 |
| NCT07753590 | A Clinical Study to Evaluate Single-agent Therapy of BR113 for Injection in Patients With… | Advanced Solid Tumors | Not Yet Recruiting | 2026-08-07 |
Breast Cancer (1)